These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6378230)

  • 1. Lack of effect of ibopamine, a dopamine pro-drug, on renal function in normal subjects.
    Harvey JN; Worth DP; Brown J; Lee MR
    Br J Clin Pharmacol; 1984 Jun; 17(6):671-7. PubMed ID: 6378230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral and renal effects of ibopamine in normal subjects.
    Incerti PL; Badalamenti S; Lorenzano E; Graziani G; Morganti A; Salerno F; Ghirardi P
    Arzneimittelforschung; 1986 Feb; 36(2A):405-7. PubMed ID: 3518727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive evaluation of the effects of oral ibopamine (SB 7505) on cardiac and renal function in patients with congestive heart failure.
    Dei Cas L; Manca C; Bernardini B; Vasini G; Visioli O
    J Cardiovasc Pharmacol; 1982; 4(3):436-40. PubMed ID: 6177940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of ibopamine on the renal functional response to extracellular volume expansion in man].
    Agnoli GC; Cacciari M; Cariani A; Garutti C; Ikonomu E; Lenzi P
    Cardiologia; 1985 Feb; 30(2):129-37. PubMed ID: 4064065
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal and humoral effects of ibopamine, a dopamine agonist, in patients with liver cirrhosis.
    Salerno F; Incerti P; Badalamenti S; Lorenzano E; Graziani G; Morganti A; Ghirardi P
    Arch Intern Med; 1990 Jan; 150(1):65-9. PubMed ID: 1967522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure].
    Wehling M; Zimmermann J; Weil J; Gerzer R; Theisen K
    Z Kardiol; 1990 Feb; 79(2):120-5. PubMed ID: 2157313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ibopamine on peripheral haemodynamics.
    Longhini C; Musacci GF; Ansani L; Toselli T; Artioli M; Bianco L; Ghirardi P
    Eur J Clin Pharmacol; 1983; 24(5):585-9. PubMed ID: 6873134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal and neurohumoral effects of ibopamine and metoclopramide in normal man.
    Girbes AR; van Veldhuisen DJ; Smit AJ; Drent-Bremer A; Meijer S; Reitsma WD
    Br J Clin Pharmacol; 1991 Jun; 31(6):701-4. PubMed ID: 1678273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibopamine (SB 7505) in normal subjects and in chronic renal failure: a preliminary report.
    Stefoni S; Colì L; Mosconi G; Prandini R
    Br J Clin Pharmacol; 1981 Jan; 11(1):69-72. PubMed ID: 7213512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracardial effects of oral ibopamine versus furosemide in patients with mild or moderate heart failure. A double-blind, randomized trial.
    Wehling M; Zimmermann J; Theisen K
    Cardiology; 1990; 77 Suppl 5():81-8. PubMed ID: 2279257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of some renal and cardiovascular effects of a prostaglandin analog, SKF 82526 and ibopamine in anesthetized dogs.
    Seymour AA; Blaine EH
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):304-15. PubMed ID: 6148046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ibopamine on diuresis in conscious rats in normal and experimentally altered conditions.
    Miragoli G; Ferrini R
    Arzneimittelforschung; 1986 Feb; 36(2A):318-22. PubMed ID: 3707642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical tolerability of ibopamine hydrochloride (SB 7505).
    Melloni GF; Melloni R; Minoja GM; Scarazzati G; Bruni GC; Loreti P; Bauer R
    Eur J Clin Pharmacol; 1981; 19(6):409-11. PubMed ID: 7250173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ibopamine, adrenolytic drugs and renal function].
    Agnoli GC; Borgatti R; Cacciari M; Dorigoni S; Garutti C; Ikonomu E; Lenzi P
    Minerva Cardioangiol; 1987 May; 35(5):241-50. PubMed ID: 2888053
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of ibopamine on renal haemodynamics in patients with severe congestive heart failure.
    Girbes AR; Kalisvaart CJ; Van Veldhuisen DJ; Tan ET; Smit AJ; Reitsma WD; Pasteuning WH
    Eur Heart J; 1993 Feb; 14(2):279-83. PubMed ID: 8095455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ibopamine on systemic, pulmonary and regional hemodynamics. Experimental investigations in anesthetized dogs.
    Merlo L; Ghirardi P; Brusoni B; Mussini E; Marchetti G
    Arzneimittelforschung; 1986 Feb; 36(2A):304-11. PubMed ID: 3707641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of chronic renal insufficiency with Ibopamine (SB 7505), a new orally active dopamine-related drug.
    Stefoni S; Docci D; Vangelista A; Mosconi G; Colí L; Prandini R
    Clin Nephrol; 1982 Oct; 18(4):168-73. PubMed ID: 6754197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-invasive evaluation of left ventricular function with systolic time intervals, in 8 normal subjects after oral treatment with di-isobutyric ester of N-methyldopamine].
    Dei Cas L; Bolognesi R; Zonca A; Vasini G; Cotogni A; Pelagatti T; Buia E
    Boll Soc Ital Cardiol; 1980; 25(6):585-92. PubMed ID: 7284163
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal effect of SB 7505: a double-blind study.
    Melloni GF; Minoja GM; Scorazzati G; Bauer R; Brusoni B; Ghirardi P
    Eur J Clin Pharmacol; 1981 Feb; 19(3):177-80. PubMed ID: 7011819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose effects of ibopamine hydrochloride on renal function in patients with congestive heart failure.
    Kasmer RJ; Cutler RE; Munger MA; Jarvis RC; Hricik D; Nara AR; Goldberg P; Green JA
    Br J Clin Pharmacol; 1990 Sep; 30(3):485-9. PubMed ID: 2223427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.